ALDX
Aldeyra Therapeutics, Inc.
Key Financials
Operating Income
$-35265206
↑ 41.3%
Net Income
$-33846661
↑ 39.4%
Total Liabilities
$27.8M
↓ 17.2%
Total Assets
$72.1M
↓ 31.1%
EPS (Diluted)
$-0.56
↑ 40.4%
Cash & Equivalents
$70.0M
↑ 28.5%
Shareholders' Equity
$44.3M
↓ 37.7%
Long-term Debt
$15.3M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ALDX |
| Company Name | Aldeyra Therapeutics, Inc. |
| CIK | 1341235 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-761-4904 |